文献速递传染病防控与疫情报告免疫规划妇幼与学校卫生

白念珠菌疫苗:从细胞壁结构到保护性免疫

Candida albicans vaccines: from cell wall architecture to protective immunity.
PubMed 文献 · Vaccine · 2026-11-01

白念珠菌是机会性真菌病原体,可定植于口腔、胃肠道和阴道黏膜,免疫抑制或毒力增强时导致复发或系统性感染。外阴阴道念珠菌病(VVC)严重影响育龄女性生活质量,唑类耐药与频繁复发限制长期疗效,亟需预防策略。本综述总结细胞壁抗原及其免疫生物学,识别转化障碍并提出推进下一代抗真菌疫苗的策略。

要点

  • 白念珠菌黏膜定植在免疫抑制下可致复发或侵袭性感染。
  • VVC主要影响育龄女性,唑类耐药和复发限制长期疗效。
  • 综述提出细胞壁抗原疫苗的转化障碍与推进策略。

核心结论

  • 针对VVC等白念珠菌感染,亟需开发预防性疫苗以应对唑类耐药和频繁复发。

研究设计与样本

  • 综述类文章,总结白念珠菌细胞壁抗原及其免疫生物学、转化障碍和疫苗策略。

主要发现

  • 白念珠菌在免疫抑制或毒力增强时大量黏膜复制并侵袭组织,导致复发浅表感染或危及生命的系统性疾病。
  • VVC主要由白念珠菌引起,显著损害育龄女性生活质量。
  • 唑类(如氟康唑)有效,但新兴耐药和频繁复发限制其长期应用。

临床怎么用

  • 为预防医学与公共卫生人员提供白念珠菌疫苗研发参考,强调VVC预防策略的紧迫性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Candida albicans is an opportunistic fungal pathogen that colonizes the oral cavity, gastrointestinal tract, and vaginal mucosa. Immunosuppression or increased fungal virulence permits extensive mucosal replication and tissue invasion, driving either recurrent superficial infection or life-threatening systemic disease. Vulvovaginal candidiasis (VVC) is predominantly caused by. It substantially impairs quality of life in women of reproductive age. Although azoles such as fluconazole are effective, emerging resistance and frequent recurrence limit their long-term utility. These constraints highlight the urgent need for preventive strategies against VVC. This review summarizes the landscape of cell wall antigens and their immunobiology, identifies key translational barriers, and proposes targeted strategies to advance next-generation antifungal vaccines, thereby providing a reference for future vaccine development.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fu J, Han X, Yao X, et al. Candida albicans vaccines: from cell wall architecture to protective immunity. Vaccine. 2026. PMID: 42967371. doi:10.1016/j.vaccine.2026.129312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。